session 8

Post on 31-Oct-2014

557 Views

Category:

Health & Medicine

1 Downloads

Preview:

Click to see full reader

DESCRIPTION

 

TRANSCRIPT

Part A: Module A8

Session 8

Skin Lesions

Part A/Module2A/Session 8

Skin lesions

80-100% of persons livng with HIV/AIDS

develop dermatological conditions

May be very disabling, disfiguring and even

life-threatening

Part A/Module2A/Session 8

Etiologies of Skin Lesions

Bacterial infection: Streptococcus aureus, streptococcus species, Treponema pallidum,

Bartonella species   Mycobacterial infection: M. tuberculosis, M. Avium complex

Viral infection: Herpes simplex and zoster virus, molluscum contagiosum, condylomata accuminata

Infestations: Scabies Fungal infection: seborrheic dermatitis, tinea corporis,

pityriasis versicolor, Cryptococcus neoformans, Histoplasma

capsulatum, Candida species  

Part A/Module2A/Session 8

Clues from presentation

Warm, inflamed, painful and/or fluctuant---a bacterial infection

Discolored skin patches----a fungal infection or

Kaposi’s sarcoma

Localized eruptions or localized pimple-like swellings--- a viral infection

  Prurigo/urticaria, macular, maculopapular or scaly

lesions-- classified as other skin conditions, including drug eruptions, seborrhea, psoriasis, and scabies

Part A/Module2A/Session 8

Possible Differentials: Skin Conditions

Bacterial Skin abscess or pyomyositisFurunculosis or folliculitisHydradenitis suppurativaImpetigo

Kaposi’s Sarcoma

Fungal Tinea, Candidiasis

Viral Herpes Simplex Condylomata

acuminataHerpes zosterMolluscum contagiosum

Part A/Module2A/Session 8

Skin Conditions, continued.

Prurigo and other skin conditions

Drug eruptions HIV-associated rash

itchy generalized maculo-papular rash Seborrheic dermatitis or generalized erythroderma Psoriasis Scabies Other dermatoses

Part A/Module2A/Session 8

Prurigo Nodularis

Part A/Module2A/Session 8

Prurigo

Part A/Module2A/Session 8

Psoriasis

Part A/Module2A/Session 8

Fixed drug eruption on cotrimoxazole

Part A/Module2A/Session 8

Stevens-Johnson in patient on thiocetazone: severe mucositis lesions

Part A/Module2A/Session 8

Seborrheic Dermatitis

Part A/Module2A/Session 8

Non-Hodgkins Lymphoma

Fever, night sweats, unexplained weight loss

Lymphadenopathy, splenomegaly, pancytopenia,

bowel obstruction, ascites, cranial nerve lesions,

spinal cord suppression, nerve root lesions,

cutaneous, testicular and lung mass lesions

Prognosis poor when CD4 is <100

Treatment is chemotherapy

Part A/Module2A/Session 8

Central Nervous System Lymphoma

End-stage complication (CD4<100)

IF no biopsy available, failure of trial of treatment for

toxo considered diagnostic of CNS lymphoma

Irradiation is palliative, no cytotoxic therapy

Survival after diagnosis limited to a few months

Part A/Module2A/Session 8

Cryptococcosis

Part A/Module2A/Session 8

Herpes Zoster--Shingles

top related